Bloomberg Reports On Generic Drug Research By Fideres

décembre 22nd, 2016
News

Fideres’s research on generic drug pricing was covered today by Bloomberg. The research analysed price increases for individual generic drugs among different manufacturers and the timings of these price increases. The coverage of Fideres’s work comes as the Department of Justice continues their investigation into alleged collusion by drug manufacturers.

The full article can be found here.

Previous PostFideres Partners Supports Filing Of Econazole Price Fixing Class Action Against Major Generic Drug Manufacturers

Next PostFideres Advises In Generic Drug Pricing Clobetasol Propionate Case

News

Fideres Contributes to ISS SCAS Publication on European Securities Litigation

Fideres is pleased to have contributed to the September 2025 ISS SCAS publication “Securities Litigation in EMEA Comes of Age” (https:/...

octobre 8, 2025

News

Fideres Publishes Empirical Study on Goldman Decisions’ Impact on Securities Class Actions

Fideres has published new research in the Berkeley Business Law Journal analyzing how the Goldman decisions are reshaping price impact challenges a...

octobre 1, 2025

News

CAT certifies Consumer Class Action Against Amazon Over Buy Box Dispute

Yesterday, the consumer class action 1595/7/7/23 Robert Hammond v Amazon.com was certified by the CAT. Evidence from Fideres had proved decisive in...